This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Linda M. Toenniessen, MD; Bentson H. McFarland, MD, PhD
Department of Psychiatry

Daniel E. Casey, MD
Departments of Psychiatry and Neurology Oregon Health Sciences University Portland, OR 97201

Arch Gen Psychiatry. 1986;43(2):191-192.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

n Reply.—

We were pleased by Drs Waddington and Molloy's positive response to our study of tardive dyskinesia (TD)¹ and encouraged by their similar findings in animals. We agree with their general conclusion that clinical investigations and studies using animal models have their greatest potential utility when designed to address complementary issues. But we remain cautious about generalizing— either to other human age groups or to other species—our clinical finding in aged psychiatric patients of a fairly brief "threshold" of neuroleptic exposure apparently associated with producing a period of maximum risk for the occurrence of TD. There are several general but related sources of our caution, the first of which is not addressed by Drs Waddington and Molloy and is problematic both in clinical investigations and in animal studies.

The potential TD risk factors of subject age and duration of neuroleptic exposure are necessarily closely related and difficult to . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?